http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/ News About Tech, Money and Innovation Wed, 25 Nov 2009 09:59:47 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/comment-page-1/#comment-777366 VentureBeat » EKR Therapeutics and the sweet revenge of “re-acquisition” Wed, 06 Feb 2008 21:19:48 +0000 http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/#comment-777366 [...] few months ago, I wrote about the intriguing trend toward “re-launching” biotech startups that had been recently acquired by Big Pharma or Big Biotech — minus, of course, whatever promising drug candidates had [...] [...] few months ago, I wrote about the intriguing trend toward “re-launching” biotech startups that had been recently acquired by Big Pharma or Big Biotech — minus, of course, whatever promising drug candidates had [...]

]]> http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/comment-page-1/#comment-610066 VentureBeat » A Facebook for the disabled, and an anti-drooling drug Thu, 01 Nov 2007 21:59:55 +0000 http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/#comment-610066 [...] along with their original management — at least in biotech. Amgen has just done this by spinning out Relypsa from the former Ilypsa. (The new names are kind of catchy, too.) Tagged N/A VentureBeat [...] [...] along with their original management — at least in biotech. Amgen has just done this by spinning out Relypsa from the former Ilypsa. (The new names are kind of catchy, too.) Tagged N/A VentureBeat [...]

]]> http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/comment-page-1/#comment-607308 DV Henkel-Wallace Wed, 31 Oct 2007 20:11:04 +0000 http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/#comment-607308 It's the Cisco model...about time! It’s the Cisco model…about time!

]]> http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/comment-page-1/#comment-601848 VentureBeat » Relypsa raises $33M for polymer drugs Mon, 29 Oct 2007 22:43:33 +0000 http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/#comment-601848 [...] our story on this Santa Clara, Calif., biotech at VentureBeat Life Sciences. Tagged N/A VentureBeat [...] [...] our story on this Santa Clara, Calif., biotech at VentureBeat Life Sciences. Tagged N/A VentureBeat [...]

]]>